An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects

Summary

The primary objectives of the study are to assess the mass balance recovery after a single dose of carbon-14 \[14C\]-A4250 as a capsule and to provide plasma, urine and faecal samples for metabolite profiling and structural identification in healthy male subjects.

Timeline

Start

2017-01-31

Primary completion

2017-03-08

Completion

2017-03-08

Drugs

Indications